The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...
Precision Biologic has announced an update of its Cryocheck Chromogenic Factor VIII assay, a test used to help diagnose and manage hemophilia A. The update, which is expected to be commercially ...
Introduction: Hereditary Angioedema (HAE) is a rare genetic disease characterized by recurrent episodes of edema and classified into HAE with C1 inhibitor deficiency (HAE-C1INH types 1 and 2) and HAE ...
BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and improving quality of life for patients. New five-year results from the phase 3 ...
SAN RAFAEL, Calif., June 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data underscoring the long-term efficacy and safety of ROCTAVIAN ® (valoctocogene ...
LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), inventor of the HCR™ technology, today announces the launch of HCR™ Pro RNA-ISH for manual workflows, expanding the unmatched performance and ...
A novel proteomics-based approach for detection of ESR1 mutant peptides in hormone receptor positive metastatic breast cancer: An exploratory study from India. This is an ASCO Meeting Abstract from ...
Background: Limulus amoebocyte lysate (LAL) is a major component of the Fungal Infection Diagnosis Kit for the adjunct diagnosis of invasive fungal infections. During the previous bleeding season, PBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback